Stockscreener 앱 받기
330.46
1.40%
4.56
시장 영업 전:
327.52
-2.94
-0.89%
전일 마감가:
$325.90
열려 있는:
$325.01
하루 거래량:
257.48K
Relative Volume:
0.87
시가총액:
$34.29B
수익:
$5.76B
순이익/손실:
$514.49M
주가수익비율:
73.74
EPS:
4.4813
순현금흐름:
$1.10B
1주 성능:
+3.69%
1개월 성능:
+18.07%
6개월 성능:
-5.58%
1년 성능:
+12.21%
1일 변동 폭
$324.16
$331.69
1주일 범위
$317.12
$331.69
52주 변동 폭
$253.95
$385.22
Beone Medicines Ltd Adr Stock (ONC) Company Profile
명칭
Beone Medicines Ltd Adr
전화
41-616851900
주소
C/O BEONE MEDICINES I GMBH, BASEL
Compare ONC vs VRTX, REGN, ARGX, RVMD, ALNY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ONC
Beone Medicines Ltd Adr
|
330.46 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
VRTX
Vertex Pharmaceuticals Inc
|
490.39 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
695.18 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
872.23 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
183.86 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
288.41 | 37.17B | 4.29B | 577.22M | 641.34M | 4.2086 |
Beone Medicines Ltd Adr Stock (ONC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-27 | 개시 | Wolfe Research | Outperform |
| 2026-03-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-11-24 | 개시 | Truist | Buy |
| 2025-09-18 | 개시 | Barclays | Overweight |
| 2025-04-07 | 개시 | RBC Capital Mkts | Outperform |
| 2025-03-03 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-12-03 | 재개 | Morgan Stanley | Overweight |
| 2024-09-18 | 개시 | JMP Securities | Mkt Outperform |
| 2024-02-06 | 재개 | JP Morgan | Overweight |
| 2023-09-12 | 개시 | Macquarie | Outperform |
| 2023-08-17 | 개시 | Jefferies | Buy |
| 2023-07-17 | 개시 | Citigroup | Buy |
| 2023-06-30 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2023-01-12 | 개시 | Daiwa Securities | Buy |
| 2022-10-13 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-10-13 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-08-09 | 재개 | JP Morgan | Overweight |
| 2022-03-17 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-02-07 | 개시 | Deutsche Bank | Buy |
| 2021-10-12 | 개시 | Bernstein | Outperform |
| 2021-10-06 | 업그레이드 | CLSA | Underperform → Buy |
| 2021-03-08 | 개시 | China Renaissance | Buy |
| 2021-03-01 | 다운그레이드 | CLSA | Outperform → Underperform |
| 2020-11-09 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2020-11-06 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2020-11-06 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
모두보기
Beone Medicines Ltd Adr 주식(ONC)의 최신 뉴스
Insider Selling: BeOne Medicines (NASDAQ:ONC) CEO Sells $15,086,671.00 in Stock - MarketBeat
Rokos Capital Management LLP Purchases Shares of 14,335 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines Ltd.Sponsored ADR $ONC Shares Bought by First Trust Advisors LP - MarketBeat
BR:B1ME34 Stock Latest News - TipRanks
BeOne Medicines AG (ONC) stock price, news, quote and history - Yahoo Finance Singapore
ONC Stock Quote Price and Forecast - CNN
Siren L.L.C. Has $138.09 Million Stock Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Temasek Holdings Private Ltd Cuts Stock Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
ABN Amro Investment Solutions Has $14.12 Million Stake in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
SEB Asset Management AB Invests $16.65 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Jennison Associates LLC Purchases 78,027 Shares of BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Assetmark Inc. Increases Stock Holdings in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
AIA Group Ltd Acquires 3,430 Shares of BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) CEO Sells 145,861 Shares of Stock - MarketBeat
BeOne Medicines (NASDAQ:ONC) CEO John Oyler Sells 11,698 Shares - MarketBeat
BeOne Medicines (NASDAQ:ONC) CEO John Oyler Sells 48,520 Shares of Stock - MarketBeat
How Chemotherapy-Free Phase 3 MCL Success At BeOne Medicines (ONC) Has Changed Its Investment Story - Sahm
Candriam S.C.A. Grows Stake in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Insider Selling: BeOne Medicines (NASDAQ:ONC) SVP Sells 664 Shares of Stock - MarketBeat
ETFs Investing in BeOne Medicines Ltd. Sponsored ADR Stocks - TradingView
ONCBeOne Medicines Ltd ADR Options - Finviz
ONC News | BEONE MEDICINES LTD-ADR (NASDAQ:ONC) - ChartMill
BeOne Medicines Advances Chemotherapy-Free Lymphoma Strategy - Sahm
49BA Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of BeOne Medicines Ltd. Sponsored ADR – DUS:49BA - TradingView
A1437N Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of BeOne Medicines Ltd. Sponsored ADR – DUS:49BA - TradingView
Price to book forward of BeOne Medicines Ltd. Sponsored ADR – DUS:49BA - TradingView
Enterprise value to revenue forward of BeOne Medicines Ltd. Sponsored ADR – TURQUOISE:ONCN - TradingView
BeOne Medicines Ltd. Sponsored ADR Actuals & Estimates (NASDAQ:ONC) - TradingView
BeOne Medicines Ltd. ADR Unsponsored Brazilian Depositary Receipt Repr 0.04 ADR - TradingView
Price to sales forward of BeOne Medicines Ltd. Sponsored ADR – TURQUOISE:ONCN - TradingView
BeOne Medicines (NASDAQ:ONC) CEO John Oyler Sells 3,410 Shares - MarketBeat
Price to book forward of BeOne Medicines Ltd. Sponsored ADR – TURQUOISE:ONCN - TradingView
Enterprise value to EBITDA forward of BeOne Medicines Ltd. Sponsored ADR – TURQUOISE:ONCN - TradingView
BeOne Medicines (NASDAQ:ONC) Insider Sells $295,558.32 in Stock - MarketBeat
Temasek Holdings Private Ltd Sells 91,877 Shares of BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Barings LLC Reduces Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Here's How Much You Would Have Made Owning BeOne Medicines Stock In The Last 10 Years - Sahm
A Look At BeOne Medicines (ONC) Valuation After Analyst Upgrades And Positive ASCO 2026 Clinical Updates - Sahm
Capital International Sarl Raises Holdings in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Is BeOne Medicines (ONC) Quietly Recasting Its Hematology Roots Into a Multi-Franchise Oncology Platform? - Sahm
BeOne Medicines Signals Solid Tumor Breakout as Three Programs Near Phase 3 - sharewise.com
《AI》BEONE MEDICINES(06160.HK) Displays Technical Pattern of Range Breakout - AASTOCKS.com
《AI》BEONE MEDICINES(06160.HK) Displays Technical Pattern of Triangle Breakout - AASTOCKS.com
Beone Medicines Ltd Adr (ONC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.60%
2.24%
자본화:
|
볼륨(24시간):